165 related articles for article (PubMed ID: 30410595)
1. Identifying a Novel Biomarker
Xiong Y; Yuan L; Chen L; Zhu Y; Zhang S; Liu X; Xiao Y; Wang X
J Cancer; 2018; 9(21):3912-3922. PubMed ID: 30410595
[TBL] [Abstract][Full Text] [Related]
2. Co-expression network analysis identified six hub genes in association with progression and prognosis in human clear cell renal cell carcinoma (ccRCC).
Yuan L; Chen L; Qian K; Qian G; Wu CL; Wang X; Xiao Y
Genom Data; 2017 Dec; 14():132-140. PubMed ID: 29159069
[TBL] [Abstract][Full Text] [Related]
3. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
[TBL] [Abstract][Full Text] [Related]
4. Identification of 9 key genes and small molecule drugs in clear cell renal cell carcinoma.
Luo Y; Shen D; Chen L; Wang G; Liu X; Qian K; Xiao Y; Wang X; Ju L
Aging (Albany NY); 2019 Aug; 11(16):6029-6052. PubMed ID: 31422942
[TBL] [Abstract][Full Text] [Related]
5. Identification of key genes and pathways in human clear cell renal cell carcinoma (ccRCC) by co-expression analysis.
Yuan L; Zeng G; Chen L; Wang G; Wang X; Cao X; Lu M; Liu X; Qian G; Xiao Y; Wang X
Int J Biol Sci; 2018; 14(3):266-279. PubMed ID: 29559845
[TBL] [Abstract][Full Text] [Related]
6. ACAT1 and Metabolism-Related Pathways Are Essential for the Progression of Clear Cell Renal Cell Carcinoma (ccRCC), as Determined by Co-expression Network Analysis.
Chen L; Peng T; Luo Y; Zhou F; Wang G; Qian K; Xiao Y; Wang X
Front Oncol; 2019; 9():957. PubMed ID: 31649873
[TBL] [Abstract][Full Text] [Related]
7. Three novel hub genes and their clinical significance in clear cell renal cell carcinoma.
Xiao H; Chen P; Zeng G; Xu D; Wang X; Zhang X
J Cancer; 2019; 10(27):6779-6791. PubMed ID: 31839812
[No Abstract] [Full Text] [Related]
8. Identification of
Yang H; Wang Y; Zhang Z; Li H
Front Genet; 2020; 11():905. PubMed ID: 32973873
[TBL] [Abstract][Full Text] [Related]
9. Identification of Biomarkers Associated With Pathological Stage and Prognosis of Clear Cell Renal Cell Carcinoma by Co-expression Network Analysis.
Chen L; Yuan L; Qian K; Qian G; Zhu Y; Wu CL; Dan HC; Xiao Y; Wang X
Front Physiol; 2018; 9():399. PubMed ID: 29720944
[TBL] [Abstract][Full Text] [Related]
10. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.
Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X
J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatic analysis identifies potentially key differentially expressed genes in oncogenesis and progression of clear cell renal cell carcinoma.
Zhang H; Zou J; Yin Y; Zhang B; Hu Y; Wang J; Mu H
PeerJ; 2019; 7():e8096. PubMed ID: 31788359
[TBL] [Abstract][Full Text] [Related]
12. Co-expression network analysis identified FCER1G in association with progression and prognosis in human clear cell renal cell carcinoma.
Chen L; Yuan L; Wang Y; Wang G; Zhu Y; Cao R; Qian G; Xie C; Liu X; Xiao Y; Wang X
Int J Biol Sci; 2017; 13(11):1361-1372. PubMed ID: 29209141
[TBL] [Abstract][Full Text] [Related]
13. Co-Expression Network Analysis Identified LTF in Association with Metastasis Risk and Prognosis in Clear Cell Renal Cell Carcinoma.
Ni L; Yuan C; Zhang C; Xiang Y; Wu J; Wang X; Wu X
Onco Targets Ther; 2020; 13():6975-6986. PubMed ID: 32764988
[TBL] [Abstract][Full Text] [Related]
14. The Identification of Key Gene Expression Signature and Biological Pathways in Metastatic Renal Cell Carcinoma.
Bao L; Zhao Y; Liu C; Cao Q; Huang Y; Chen K; Song Z
J Cancer; 2020; 11(7):1712-1726. PubMed ID: 32194783
[No Abstract] [Full Text] [Related]
15. Bioinformatic analysis identifying FGF1 gene as a new prognostic indicator in clear cell Renal Cell Carcinoma.
Zhang X; Wang Z; Zeng Z; Shen N; Wang B; Zhang Y; Shen H; Lu W; Wei R; Ma W; Wang C
Cancer Cell Int; 2021 Apr; 21(1):222. PubMed ID: 33865387
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Novel Immune-Related Prognostic Biomarker and Small-Molecule Drugs in Clear Cell Renal Cell Carcinoma (ccRCC) by a Merged Microarray-Acquired Dataset and TCGA Database.
Xiao GF; Yan X; Chen Z; Zhang RJ; Liu TZ; Hu WL
Front Genet; 2020; 11():810. PubMed ID: 33014010
[TBL] [Abstract][Full Text] [Related]
17. GNRH1 and LTB4R might be novel immune-related prognostic biomarkers in clear cell renal cell carcinoma (ccRCC).
Wu HH; Yan X; Chen Z; Du GW; Bai XJ; Tuoheti K; Liu TZ
Cancer Cell Int; 2021 Jul; 21(1):354. PubMed ID: 34229684
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Topoisomerase 2-Alpha Confers a Poor Prognosis in Pancreatic Adenocarcinoma Identified by Co-Expression Analysis.
Zhou Z; Liu S; Zhang M; Zhou R; Liu J; Chang Y; Zhao Q
Dig Dis Sci; 2017 Oct; 62(10):2790-2800. PubMed ID: 28815403
[TBL] [Abstract][Full Text] [Related]
19. LGALS1 was related to the prognosis of clear cell renal cell carcinoma identified by weighted correlation gene network analysis combined with differential gene expression analysis.
Fang J; Wang X; Xie J; Zhang X; Xiao Y; Li J; Luo G
Front Genet; 2022; 13():1046164. PubMed ID: 36712844
[TBL] [Abstract][Full Text] [Related]
20. Functional Assessment of Four Novel Immune-Related Biomarkers in the Pathogenesis of Clear Cell Renal Cell Carcinoma.
Lv D; Wu X; Wang M; Chen W; Yang S; Liu Y; Zeng G; Gu D
Front Cell Dev Biol; 2021; 9():621618. PubMed ID: 33796525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
